2010 full-year results 3 March 2011 - UCB
2010 full-year results 3 March 2011 - UCB
2010 full-year results 3 March 2011 - UCB
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Cimzia ®<br />
Fast response for predictable outcomes<br />
Rheumatoid arthritis - Fast response for predictable outcomes<br />
• Fast response with Cimzia ® means<br />
• Improved long-term outcomes<br />
• The opportunity to make an informed treatment decision within 12 weeks<br />
Crohn’s disease (approved in Switzerland)<br />
For naïve or bio-experienced patients<br />
• Fast – Results after just 1 dose<br />
• Sustainable – Long-term remission with no dose escalation<br />
• Stable – 1 predictable subcutaneous Q4-week dose<br />
Net sales increased by 528%<br />
€ million<br />
Europe<br />
ROW<br />
<strong>2010</strong><br />
net sales<br />
31<br />
1<br />
2009<br />
net sales<br />
5<br />
0<br />
~ 4 000 patients on Cimzia ®<br />
19
Change language